MedPath

Vexa

Vexa-D

Approved
Approval ID

85933294-59de-4465-a02c-4225f0c20ce8

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Mar 24, 2015

Manufacturers
FDA

Pharmaceutics Corporation

DUNS: 079132026

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lidocaine, Allantoin, Petrolatum

PRODUCT DETAILS

NDC Product Code49430-053
Application NumberN/A
Marketing CategoryN/A
Route of AdministrationTOPICAL
Effective DateMarch 20, 2015
Generic NameLidocaine, Allantoin, Petrolatum

INGREDIENTS (5)

ALLANTOINActive
Quantity: 2 mg in 1 1
Code: 344S277G0Z
Classification: ACTIB
LIDOCAINEActive
Quantity: 4 mg in 1 1
Code: 98PI200987
Classification: ACTIB
PETROLATUMActive
Quantity: 30 mg in 1 1
Code: 4T6H12BN9U
Classification: ACTIB
ONIONInactive
Code: 492225Q21H
Classification: IACT
.ALPHA.-TOCOPHEROLInactive
Code: H4N855PNZ1
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Vexa - FDA Drug Approval Details